Tailored Treatment for Specific Health Conditions

Tailored Treatment for Specific Health Conditions

 

That discovery over 25 years ago is viewed today as one of the remarkable elements in transfer factors effectiveness. Transfer factors acts as a "tailored" treatment by communicating the exact immunological information from the donor to the recipient regarding a single or as many as thousands of specific antigens.

 

In 1970 Dr Hugh Fudenberg et al began using transfer factors as treatment on patients suffering from Wiscott-Aldrich Syndrome. His scope later widened to include candidiasis (yeast infection) several viral type cancers as well as fungal and parasitic diseases (reviewed in reference 6).

 

Research efforts subsided somewhat during the 1970's largely due to the high price tag coupled with a focus on mostly rare viruses. Even so immunologists remained very interested in transfer factors potential and research slowly but surely moved forward.

 

Over the next decade there were continuing revelations about the nature and targeted effectiveness of transfer factors. For example tests were conducted in 1981 by Dr Kahn et al (7) in seventeen patients with herpes who were given injections containing transfer factors at intervals of one week to 3 months with noteworthy results. Sixteen of the seventeen patients involved in the study showed definite decreases in recurrence with eight of those treated being completely free of the disease. T-cell function improved significantly and it was likewise noted that transfer factors induced interferon (production) increase.

 

A 29 year old woman with a long history of low immune resistance contracted both generalized herpes zoster and varicella pneumonia in 1985. Her condition was described as "desperate" due to respiratory failure and an overall degrading chest condition. She responded quickly after treatment with transfer factors from a healing herpes donor (8). Once again this case points to ability of transfer factors to effectively target specific antigens.

 

The Epstein-Barr virus in combination with a cytomegalovirus (CMV) infection was treated in a four year old child who had suffered for two years with recurring fevers rashes abdominal pain and other nagging symptoms (9). He was then given products containing transfer factors by mouth. Incredibly his symptoms disappeared and the child even developed a specific CMV immunity.

 

Additional case studies revealed transfer factors effectiveness in treating candidiasis cryptosporosis and Burkitt's lymphoma (10-13). Even as the general public was only beginning to hear terms like HIV and AIDS in the 1980's transfer factors treatment attempts had begun for HIV patients suffering from severe viral diarrhea (14). Of the seven patients treated with transfer factors six patients gained weight and showed a decrease in bowel movement frequency. Other AIDS cases resulted in partial immune system enhancement when treated with transfer factor.